BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhu X, Dresser K, Chen BJ. Loss of 5‐hydroxymethylcytosine immunohistochemical expression is a useful diagnostic aid for distinguishing hepatocellular carcinoma in cytology fine needle aspiration specimens. Cytopathology 2019;30:492-8. [DOI: 10.1111/cyt.12719] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Z, Jin Y, Zhang W, Chu C, Zhang K, Gao X, Zhou J, Zou L, Tang F, Wang H, Zou Q. Values of 5mC, 5hmC, and TET2 for identifying the presence and progression of breast precancerous lesion. J Clin Lab Anal 2020;34:e23162. [PMID: 31867779 DOI: 10.1002/jcla.23162] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Xu T, Gao H. Hydroxymethylation and tumors: can 5-hydroxymethylation be used as a marker for tumor diagnosis and treatment? Hum Genomics 2020;14:15. [PMID: 32375881 DOI: 10.1186/s40246-020-00265-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Oishi N, Vuong HG, Mochizuki K, Kondo T. Loss of 5-Hydroxymethylcytosine is an Epigenetic Hallmark of Thyroid Carcinomas with TERT Promoter Mutations. Endocr Pathol 2020;31:359-66. [PMID: 33058026 DOI: 10.1007/s12022-020-09652-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]